Toronto, Ontario, October 10th, 2019 — After being provided facts about the severity of diabetes and the cost to the Canadian health care system, two-thirds (67%) of Canadians say they would be more likely to vote for/support a political party that prioritized national diabetes program/strategy. Six in ten (59%) Canadians are touched by diabetes in some way, either living with the disease, have prediabetes, caring for someone who has diabetes, have been told they are at high risk, or having a family member who has been diagnosed. Those touched by diabetes are significantly more likely to support a party who prioritized a national diabetes strategy (76% support vs. 54% no experience with diabetes).
A similar proportion of Canadians (63%) also say they would be more likely to support/vote for a local federal candidate if they prioritized such a plan. Again, those touched by the disease are significantly more likely to offer support (72% support vs. 50% no experience with diabetes).
Three-quarters (77%) are concerned with the prevalence of diabetes in Canada and seven in ten (69%) are concerned about the costs of diabetes to the Canadian healthcare system. Those closest to the disease, either living with it themselves or providing care to some who is, are significantly more concerned about the prevalence of diabetes in Canada (88% concerned vs. 68% no experience with diabetes) and the cost to the Canadian healthcare system (83% concerned vs. 62% no experience with diabetes).
About the Study
These are some of the findings of an Ipsos poll conducted between September 30th and October 3rd, 2019, on behalf of Diabetes Canada. For this survey, a sample of 1,270 Canadians aged 18+ were interviewed. Weighting was then employed to balance demographics to ensure that the sample's composition reflects that of the adult population according to Census data and to provide results intended to approximate the sample universe. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll is accurate to within ±3.1 percentage points, 19 times out of 20, had all Canadians aged 18+ been polled. The credibility interval will be wider among subsets of the population. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error, and measurement error.
For more information on this Factum, please contact:
Jennifer McLeod Macey
Vice President, Ipsos Public Affairs
+1 416 324-2108
Ipsos is the world’s third largest market research company, present in 90 markets and employing more than 18,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions.
Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
[WEBINAR] The Future of Beauty: Thriving Across the Consumer Decision Journey
The Beauty industry is now more fragmented and disrupted than ever in history. Beauty companies are challenged to stay ahead and lead the trends, as well to best predict whether or not they’ve developed the next biggest innovation.